April 2013 Issue Table Of Contents

From The Editor

• Let’s Incentivize Innovation – Before It’s Too Late

Ask The Board

• Ask The Board April 2013

Capitol Perspectives

• Why Is The President Attacking The Successful Medicare Part D Program?

Companies To Watch

• Companies To Watch: StemCells

Outsourcing Insights

• Outsourcing And The Oral Solid Dose — Will Challenges Lead To New Patterns Of Outsourcing?

Bio Innovation notes

• Vendors Ignore Calls For Innovation In Assays

Feature

• GSK Pushes Into Innovation Investment
• Protecting U.S. Medical Innovation – A Call To Action From Celegene’s CEO

Inside The Industry

• How Pfizer Navigates Changing Biosimilar Regulations
• The Cold Chain: What You Don’t Know
• Finding The Gaps In Your Logistics Plan
• Parenterals, Prefills, & Purity: Are Suppliers Up To The Challenge?
• Why Regulatory Intelligence Is More Important Than Ever
• Steps To Get Your Life Sciences Company In Shape In 2013
• One-On-One With The Industry’s Players At JPMHC
• Biotechnology In The U.K.: Growing And Changing

Industry Leader

• A Successful Externalization Strategy Demands Modernized Informatics
• New Approaches To Improve Vaccine Manufacturing
• Yes, But Do They Trust You?